Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety
NCT ID: NCT06035211
Last Updated: 2025-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
192 participants
INTERVENTIONAL
2023-09-19
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery for Renal Tumor.
NCT03943771
Rein 3D PRINT PERSONALIZE
NCT06379698
3D-biomodels for Surgical Planning in Patients With Renal Cancer and Vascular Involvement
NCT03738488
Pre-emptive Kidney Transplantation Quality of Life
NCT02154815
"Lived Experience, Representations and Psychic Processes in Patients Awaiting Kidney Transplantation"
NCT02690272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Technological development in healthcare has seen the rising of three-dimensional media, especially in surgery, for procedure planning. There is no doubt that this tool is effective in helping surgeons regarding the studies published within the past few years but there is no such evidence concerning the benefit for patients. Some authors report improvement of patients understanding and great satisfaction referring to the usefulness of this tool. But none of these papers evaluated anxiety.
The goal of this research is to measure the effect of a personalized three-dimensional model of patients' tumoral kidney on peri-operative anxiety.
For this purpose this clinical trial is designed as following: a total of 234 (78\*3) patients planned to have a nephron-sparing surgery for kidney tumor are going to be randomly assign in 3 different groups. Inside the 2 interventional groups, patients' kidneys will be modelled in three dimensions, but in one of the two groups, the model will be 3D-printed. The control group will include patients for whom the pre-operative information will be made based on standardized information letter from the French Urological Association.
Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group. All patients will have to complete questionnaires to assess their anxiety level, their quality of life, their health literacy level and their understanding of disease and surgical procedure.
One month after surgery, during the post-operative consultation, patients will also fill out the different questionnaires to assess their anxiety level, quality of life, and level of litteracy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Virtual 3D model group
exchange time with the virtual 3D model of the kidney to be operated on as information support
3D model pré-operative education
Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group
3D Printed Model Group
eexchange time with the printed three-dimensional model of the kidney to be operated on as information support
3D model pré-operative education
Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group
Control group
discussion time with the patient information sheet of the French Association of Urology (AFU) as information support
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D model pré-operative education
Before surgery, during a preoperative therapeutic education consultation, 3D models will be presented to the patients according to the allocated study group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled surgical management by laparoscopic partial nephrectomy with robotic assistance for kidney tumor
* Unilateral kidney tumor or 1st surgery for bilateral involvement
* Consent expressed for integration of the UroCCR cohort,
* Expressed consent for participation in the 3D Anxiety study.
* Patients affiliated or benefiting from a social security plan
Exclusion Criteria
* Difficulty understanding and expressing oneself in French
* Patient under guardianship or curatorship
* No preoperative CT scan available for 3D modeling
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Christophe BERNHARD, Professeur
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU d'ANGERS
Angers, , France
CHU de Bordeaux
Bordeaux, , France
CHU de CAEN
Caen, , France
Hôpital Kremlin-Bicêtre
Le Kremlin-Bicêtre, , France
CHU de La CONCEPTION
Marseille, , France
CHU de NANTES
Nantes, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Pierre BIGOT, Pr.
Role: primary
Jean-Christophe BERNHARD, Pr.
Role: primary
Thibaut WAECKEL, Dr.
Role: primary
Sébastien PARIER, Dr.
Role: primary
Romain BOISSIER, Pr.
Role: primary
Stéphane De VERGIE, Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHUBX 2022/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.